Neuroone Medical Technologies (NMTC) Convertible Debt (2017 - 2020)

Neuroone Medical Technologies' Convertible Debt history runs 4 years deep, the most recent figure standing at $1.0 million for Q3 2020.

• Quarterly Convertible Debt changed N/A year-over-year to $1.0 million in Q3 2020, while the trailing twelve-month figure through Sep 2020 was $1.0 million (changed N/A YoY) and the FY2020 annual result came in at $1.0 million, changed N/A from the prior year.
• Convertible Debt was $1.0 million for Q3 2020 at Neuroone Medical Technologies, down from $6.7 million in the prior quarter.
• Across five years, Convertible Debt topped out at $6.7 million in Q2 2020 and bottomed at $1.0 million in Q3 2020.
• A 4-year average of $3.0 million and a median of $2.1 million in 2018 frame the typical range for Convertible Debt.
• Annual changes were most pronounced in 2018 — Convertible Debt declined 23.54% — and 2019, when it jumped 213.2%.
• Neuroone Medical Technologies' Convertible Debt stood at $2.2 million in 2017, then retreated by 23.54% to $1.7 million in 2018, then soared by 213.2% to $5.2 million in 2019, then tumbled by 80.6% to $1.0 million in 2020.
• Business Quant data shows NMTC's Convertible Debt at $1.0 million in Q3 2020, $6.7 million in Q2 2020, and $4.9 million in Q1 2020.